Breaking News Instant updates and real-time market news.

AXP

American Express

$72.86

-0.02 (-0.03%)

, BAYRY

Bayer

$94.14

0.855 (0.92%)

07:11
11/28/16
11/28
07:11
11/28/16
07:11

Radiological Society of North America to hold a conference

RSNA 2016 is being held in Chicago on November 27-December 2.

AXP

American Express

$72.86

-0.02 (-0.03%)

BAYRY

Bayer

$94.14

0.855 (0.92%)

BTC

Community Bankers

CAJ

Canon

$28.25

0.17 (0.61%)

CERN

Cerner

$50.49

-0.02 (-0.04%)

VAR

Varian Medical

$92.14

0.52 (0.57%)

  • 29

    Nov

  • 29

    Nov

  • 29

    Nov

  • 30

    Nov

  • 07

    Dec

AXP American Express
$72.86

-0.02 (-0.03%)

11/18/16
11/18/16
INITIATION
Target $62

Underweight
Discover initiated with an Underweight at Stephens
As previously reported, Stephens analyst Vincent Caintic started Discover (DFS) with an Underweight rating and $62 price target, citing shrinking margins as American Express (AXP) ramps up rewards to maintain share, credit costs normalizing higher likely making Discover's shares range bound, and personal lending competition. The analyst also started American Express with an Underweight rating.
11/18/16
11/18/16
INITIATION
Target $40

Overweight
Synchrony initiated with an Overweight at Stephens
As previously reported, Stephens analyst Vincent Caintic started Synchrony (SYF) with an Overweight rating and $40 price target, citing $5B excess capital that allows Synchrony to buy back 20% of company once capital return is deregulated, industry retail share weakness, and revenue growth. The analyst also started American Express (AXP) and Discover (DFS) with an Underweight rating.
11/18/16
11/18/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Cisco (CSCO) coverage resumed with a Hold at Stifel. 2. UPS (UPS) was initiated with an Outperform at BMO Capital while the firm initiated FedEx (FDX) with a Market Perform. 3. Synchrony (SYF) was initiated with an Overweight at Stephens. The firm also initiated American Express (AXP) and Discover (DFS) with an Underweight. 4. American Airlines (AAL), Delta Air Lines (DAL), Southwest (LUV) and Allegiant Travel (ALGT) were initiated with a Buy at Citi while the firm initiated JetBlue (JBLU), United Continental (UAL), Alaska Air (ALK), and Hawaiian Holdings (HA) with a Neutral. 5. Juniper (JNPR) coverage resumed at Stifel. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
11/18/16
11/18/16
INITIATION
Target $65

Underweight
American Express initiated with an Underweight at Stephens
As previously reported, Stephens analyst started American Express (AXP) with an Underweight rating and $65 price target, citing rising rates, shrinking markets as American Express ramps up rewards to maintain share, and the risk to 2017 EPS guidance. The analyst expects competition from bank peers, such as JPMorgan (JPM) and Citi (C), to continue to pressure American Express' earnings.
BAYRY Bayer
$94.14

0.855 (0.92%)

09/26/16
BERN
09/26/16
UPGRADE
BERN
Market Perform
Monsanto upgraded on acquisition at Bernstein
As noted earlier, Bernstein upgraded Monsanto (MON) to Market Perform from Underperform. Analyst Jonas Oxgaard upgraded the stock after Bayer (BAYRY) agreed to buy Monsanto. However, he warned that "it's too early to tell" whether regulators will approve the deal, and he says that the risk is "skewed to the downside in the near-term." He recommends that investors avoid the stock for 6-9 months. Target to $105 from $90.
09/15/16
PIPR
09/15/16
NO CHANGE
Target $128
PIPR
Overweight
Piper has confidence in closing of Monsanto, Bayer merger
Piper Jaffray analyst Brett Wong raised his price target for Monsanto (MON) to $128 citing the takeover price paid by Bayer (BAYRY). The analyst views the offer price as lower than expected but has confidence regulatory approval will be granted since there is a minimal crossover between the two companies. He reiterates an Overweight rating on Monsanto.
09/15/16
BERN
09/15/16
NO CHANGE
BERN
Bayer acquisition negative, says Bernstein
After Bayer (BAYRY) agreed to buy Monsanto (MON), Bernstein analyst Jonas Oxgaard says he "continues to have a bearish view" of Monsanto's business, and he thinks that Monsanto's price exceeded the company's true value by about 60%. The analyst adds that the genetically modified products that Monsanto is developing "are not expected to command outsized premiums," while genetically modified seeds have nearly fully penetrated most of the Americas. He keeps an Underperform rating on Monsanto and an Outperform rating on Bayer.
09/21/16
JPMS
09/21/16
UPGRADE
Target $128
JPMS
Overweight
Monsanto upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Jeffrey Zekauskas upgraded Monsanto (MON) to Overweight saying the risk in the shares is "less than what the market assumes." The analyst believes downside risk should the takeover by Bayer (BAYRY) fail is around $100 per share. He notes that Monsanto shareholders would receive $128 per share should the acquisition close. Zekauskas raised his price target for Monsanto to $128 from $100.
BTC Community Bankers

CAJ Canon
$28.25

0.17 (0.61%)

10/27/16
BOFA
10/27/16
DOWNGRADE
BOFA
Underperform
Canon downgraded to Underperform from Neutral at BofA/Merrill
10/26/16
JPMS
10/26/16
DOWNGRADE
JPMS
Underweight
Canon downgraded to Underweight from Neutral at JPMorgan
11/25/16
LYON
11/25/16
UPGRADE
LYON
Outperform
Canon upgraded to Outperform from Underperform at CLSA
07/15/16
LYON
07/15/16
DOWNGRADE
LYON
Underperform
Canon downgraded to Underperform from Buy at CLSA
CLSA analyst Claudio Aritomi downgraded Canon to Underperform from Buy saying there is a high probability Canon will cut its guidance for FY16 along with 2Q results.
CERN Cerner
$50.49

-0.02 (-0.04%)

11/17/16
KEYB
11/17/16
NO CHANGE
KEYB
Cerner outlook still positive, says KeyBanc
KeyBanc analyst Donald Hooker says that President-elect Trump's victory "creates near-term uncertainty for Cerner's population health businesses." However, the analyst expects the company's revenue cycle businesses to continue to grow by at least 10%. He predicts that the company will exploit the Trump Administration's more favorable stance towards drug development by providing information to life sciences companies. He keeps a $77 price target and an Outperform rating on the shares.
11/10/16
DBAB
11/10/16
DOWNGRADE
DBAB
Hold
Cerner, Allscripts downgraded to Hold on ACA uncertainty at Deutsche Bank
As previously reported, Deutsche Bank analyst George Hill downgraded Cerner (CERN) and Allscripts (MDRX), both to Hold from Buy, citing the "high likelihood" that the Affordable Care Act gets repealed or significantly scaled back following the election of Donald Trump. Given the likely repeal, and uncertainty on what will replace the ACA, Hill sees a less certain outlook for hospital based IT spending. Hill cut his price target on Cerner to $50 from $58 and on Allscripts to $11 from $14.
11/10/16
DBAB
11/10/16
DOWNGRADE
DBAB
Hold
Cerner downgraded to Hold from Buy at Deutsche Bank
11/07/16
BOFA
11/07/16
DOWNGRADE
BOFA
Underperform
Cerner downgraded to Underperform on capex slowdown at BofA/Merrill
As previously reported, BofA/Merrill downgraded Cerner to Underperform from Neutral and lowered its price target to $51 from $61. Analyst Steven Valiquette believes hospital customers are "tightening the belts" further in 2017 given reimbursement challenges and expects the company to see slower growth than in prior years. .
VAR Varian Medical
$92.14

0.52 (0.57%)

01/12/16
BRRR
01/12/16
INITIATION
Target $91
BRRR
Outperform
Varian Medical assumed with an Outperform at Barrington
Barrington analyst Michael Petusky assumed coverage of Varian Medical with an Outperform rating and $91 price target.
04/28/16
BMUR
04/28/16
NO CHANGE
Target $87
BMUR
Buy
Varian Medical price target raised to $87 from $82 at Brean Capital
Brean Capital raised its price target on Varian Medical to $87 from $82 following mixed Q2 results. The firm cited its lowered guidance, which they now see as achievable. Brean Capital reiterated its Buy rating on Varian Medical shares.
07/08/16
BARD
07/08/16
NO CHANGE
Target $84
BARD
Neutral
No change in PFS proposed rates a positive for Varian Medical, says Baird
Baird analyst Jeff Johnson noted that CMS released CY 2017 proposed payment rates under the Physician Fee Schedule and said the flat proposed rate changes for a typical radiation freestanding center next year is a positive for Varian Medical. While the flat proposed rate is in-line with management guidance, will still likely come as a relief for investors, said Johnson, who keeps a Neutral rating and $84 price target on Varian shares.
10/20/16
SBSH
10/20/16
NO CHANGE
SBSH
General Electric takeover of Varian Medical unlikely, says Citi
Citigroup said General Electric (GE) exited the radiation oncology space in the 1990's and since then has had virtually no interest in getting into the treatment side of healthcare versus diagnostics. Further, the firm's analyst said Varian (VAR) is in the midst of spinning off their imaging business, and in theory, would make Varian a much more attractive target for General Electric. However, Citi said a takeover of Varian before the spin closing in December would make no sense by General Electric and reduces the firm's belief in today's speculation.

TODAY'S FREE FLY STORIES

CVM

CEL-SCI

$0.10

-0.0099 (-9.00%)

08:09
04/28/17
04/28
08:09
04/28/17
08:09
Hot Stocks
CEL-SCI says European Patent office to grant new Multikine patent »

CEL-SCI Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SYF

Synchrony

$33.05

-0.18 (-0.54%)

08:09
04/28/17
04/28
08:09
04/28/17
08:09
Technical Analysis
Synchrony drops sharply after earnings miss consensus »

The stock was last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 18

    May

  • 31

    May

MSFT

Microsoft

$68.27

0.44 (0.65%)

08:09
04/28/17
04/28
08:09
04/28/17
08:09
Recommendations
Microsoft analyst commentary  »

Microsoft commercial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 09

    May

RCL

Royal Caribbean

$100.50

0.03 (0.03%)

08:08
04/28/17
04/28
08:08
04/28/17
08:08
Hot Stocks
Royal Caribbean sees FY17 CapEx $0.6B »

Based upon current ship…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

ACBI

Atlantic Capital

08:07
04/28/17
04/28
08:07
04/28/17
08:07
Earnings
Atlantic Capital reports Q1 EPS 13c, consensus 14c »

Taxable equivalent net…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 18

    May

RCL

Royal Caribbean

$100.50

0.03 (0.03%)

08:07
04/28/17
04/28
08:07
04/28/17
08:07
Earnings
Royal Caribbean sees Q2 adjusted EPS $1.60-$1.65, consensus $1.44 »

Constant-Currency Net…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

XOM

Exxon Mobil

$81.26

-0.14 (-0.17%)

08:07
04/28/17
04/28
08:07
04/28/17
08:07
Hot Stocks
Exxon Mobil reports Q1 capital and exploration expenditures down 19% »

Capital and exploration…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

MXWL

Maxwell

$6.24

-0.03 (-0.48%)

08:06
04/28/17
04/28
08:06
04/28/17
08:06
Earnings
Maxwell sees Nesscap Energy acquisition immediately accretive to non-GAAP EPS »

Acquisition is expected…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

  • 13

    Jul

RTN

Raytheon

$156.26

0.99 (0.64%)

08:06
04/28/17
04/28
08:06
04/28/17
08:06
Recommendations
Raytheon analyst commentary  »

Raytheon price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

RCL

Royal Caribbean

$100.50

0.03 (0.03%)

08:05
04/28/17
04/28
08:05
04/28/17
08:05
Hot Stocks
Breaking Hot Stocks news story on Royal Caribbean »

Royal Caribbean announces…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

CIR

CIRCOR

$65.03

-0.22 (-0.34%)

08:05
04/28/17
04/28
08:05
04/28/17
08:05
Earnings
CIRCOR reports Q1 adjusted EPS 32c, consensus 35c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 10

    May

XOM

Exxon Mobil

$81.26

-0.14 (-0.17%)

08:05
04/28/17
04/28
08:05
04/28/17
08:05
Hot Stocks
Exxon Mobil says Downstream earnings benefited from increased throughput »

Exxon Mobil reports Q1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

TPIC

TPI Composites

$19.57

-0.27 (-1.36%)

08:05
04/28/17
04/28
08:05
04/28/17
08:05
Hot Stocks
TPI Composites enters wind blade supply agreement with Vestas »

TPI Composites announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    May

BLDP

Ballard Power

$3.14

0.14 (4.67%)

08:05
04/28/17
04/28
08:05
04/28/17
08:05
Technical Analysis
Ballard Power ticks 52-week high in pre-market »

Shares were last at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

RCL

Royal Caribbean

$100.50

0.03 (0.03%)

08:05
04/28/17
04/28
08:05
04/28/17
08:05
Hot Stocks
Royal Caribbean reports Q1 net yields up 6% on constant currency basis »

Q1 Net Yields were up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

RCL

Royal Caribbean

$100.50

0.03 (0.03%)

08:04
04/28/17
04/28
08:04
04/28/17
08:04
Hot Stocks
Royal Caribbean says booked position remains at record level »

For FY17: Overall, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

XOM

Exxon Mobil

$81.26

-0.14 (-0.17%)

08:04
04/28/17
04/28
08:04
04/28/17
08:04
Hot Stocks
Exxon Mobil reports Q1 Upstream volumes down 4% from prior year »

Exxon Mobil reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

PFS

Provident Financial

$26.44

-0.21 (-0.79%)

08:04
04/28/17
04/28
08:04
04/28/17
08:04
Earnings
Provident Financial reports Q1 EPS 37c, consensus 36c »

Reports Q1 book value per…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 15

    May

MA

MasterCard

$117.10

0.93 (0.80%)

08:03
04/28/17
04/28
08:03
04/28/17
08:03
Hot Stocks
MasterCard names Ed McLaughlin president of operations and technology »

Mastercard announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 31

    May

WCC

WESCO

$62.60

-5.4 (-7.94%)

08:03
04/28/17
04/28
08:03
04/28/17
08:03
Recommendations
WESCO analyst commentary  »

WESCO price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

  • 07

    Jun

TIME

Time Inc.

$18.30

-0.3 (-1.61%)

08:03
04/28/17
04/28
08:03
04/28/17
08:03
Earnings
Time Inc. backs FY17 outlook, sees revenue approx. $3B, consensus $3B »

Previously forecast…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RCL

Royal Caribbean

$100.50

0.03 (0.03%)

08:03
04/28/17
04/28
08:03
04/28/17
08:03
Earnings
Royal Caribbean raises FY17 adjusted EPS view to $7.00-$7.20, consensus $7.06 »

Prior view was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

XOM

Exxon Mobil

$81.26

-0.14 (-0.17%)

08:03
04/28/17
04/28
08:03
04/28/17
08:03
Hot Stocks
Exxon Mobil says results reflect commodity price increases, better cost control »

"Our results reflect…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

RBS

RBS

$6.54

0.05 (0.77%)

08:02
04/28/17
04/28
08:02
04/28/17
08:02
Technical Analysis
RBS trades higher following results »

In the pre-market shares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TIME

Time Inc.

$18.30

-0.3 (-1.61%)

08:02
04/28/17
04/28
08:02
04/28/17
08:02
Hot Stocks
Breaking Hot Stocks news story on Time Inc. »

Time Inc. affirms that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.